Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication

Psilocybin is being investigated as a treatment in adults with treatment-resistant depression (TRD). Withdrawal from serotonergic antidepressant drugs is a common prerequisite for taking part in trials of psilocybin due to the possibility of ongoing antidepressant drugs altering the psychedelic effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Goodwin, Guy M., Croal, Megan, Feifel, David, Kelly, John R., Marwood, Lindsey, Mistry, Sunil, O’Keane, Veronica, Peck, Stephanie Knatz, Simmons, Hollie, Sisa, Claudia, Stansfield, Susan C., Tsai, Joyce, Williams, Sam, Malievskaia, Ekaterina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425429/
https://www.ncbi.nlm.nih.gov/pubmed/37443386
http://dx.doi.org/10.1038/s41386-023-01648-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425429/
https://www.ncbi.nlm.nih.gov/pubmed/37443386
http://dx.doi.org/10.1038/s41386-023-01648-7

Ejemplares similares